Libo Xu

613 citations
28 papers · 414 · h-index 11

Impact in

Papers in

    • Cancer therapeutics and mechanisms 4
    • Metabolism, Diabetes, and Cancer 3
    • Peroxisome Proliferator-Activated Receptors 2
    • Phenothiazines and Benzothiazines Synthesis and Activities 2
    • Surfactants and Colloidal Systems 2
    • Advanced Polymer Synthesis and Characterization 2

Libo Xu

27 papers receiving 399 citations

Peers

Libo Xu
Comparison fields: 5 of 89
  • Physiology 25
  • Microbiology 4
  • Toxicology 15
  • Pharmacology 69
  • Molecular Biology 199
Replace Arnab Sarkar with:
Arnab Sarkar India
Sarah Tomas‐Hernández Spain
Philippe Chabert France
Ravinder Earla United States
Roberto Nuti Italy
Shien Zou China
Giampiero Colombano Italy
Diego Eidy Chiba Brazil
P. Scorza Barcellona Italy
Manal Mohammed India
Libo Xu relative to Arnab Sarkar India Arnab Sarkar's profile →
Citations per field
00.5×6.5×
Arnab Sarkar · 1×
Citations per year

Countries citing papers authored by Libo Xu

Since Specialization
Citations

This map shows the geographic impact of Libo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Xu more than expected).

Fields of papers citing papers by Libo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Libo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Xu. The network helps show where Libo Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Libo Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Libo Xu Line = papers co-authored together Libo Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200074
2 200056
3 200947
4 200533
5 200928
6 202025
7 201219
8 200718
9 201717
10 200516
11 202211
12 20259
13 20178
14 20257
15 20237
16 20206
17 20206
18 20256
19 20205
20 20224

About Libo Xu

Libo Xu is a scholar working on Molecular Biology, Organic Chemistry, Epidemiology, Electrical and Electronic Engineering and Pharmacology, having authored 28 papers that have together received 414 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Gestational Diabetes Research and Management (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Surfactants and Colloidal Systems (2 papers), Advanced Polymer Synthesis and Characterization (2 papers), Adipose Tissue and Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). The work is most often cited by research in Physiology (25 citations), Microbiology (4 citations), Toxicology (15 citations), Pharmacology (69 citations) and Molecular Biology (199 citations). Libo Xu has collaborated with scholars based in China and United States. Frequent co-authors include David E. Moller, A. Brian Jones, Peter T. Meinke, Victor Ding, Bei B. Zhang, Deborah Szalkowski, Kun Liu, James V. Heck, S.-E. W. Huskey and Gloria Y. Kwei. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Global Health, Journal of Surfactants and Detergents, Bioorganic & Medicinal Chemistry Letters and BMC Pregnancy and Childbirth.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact